Silo Pharma (Nasdaq: SILO) (“Silo” or “the Company”), a diversified developmental-stage biopharmaceutical company with a therapeutic focus on addressing underserved conditions, including ...

Precision oncology is reshaping cancer care in India, driven by cheaper sequencing, AI‑powered mutation discovery, and pharma ...

A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing ...

The addition of Klow peptide 80mg represents another catalog expansion within Dragon Pharma Store's research materials portfolio. The updated listing provides researchers with access to additional ...

Forward-thinking manufacturers build native compliance protocols as a workflow, not as an afterthought—a pitfall that many ...

Companies see a commercial opportunity in creating new ways to administer drugs to patients – in space.

Driven by personal losses, major unmet needs and a desire to diversify from the crowded oncology market, Fosun Pharma is ...

In the past six months, there have been 33 biotech acquisitions valued at $1 billion or more, capped by AbbVie’s acquisition ...

Indian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key ...

For years, pure-play pharma product campaigns took the top plaudits but, since the COVID pandemic in 2020, there has been a notable shift. In the post-pandemic years, pharma took a backseat to medical ...

Three mid-cap biotechs have become prime acquisition targets, but only one offers what big pharma is hunting for most.

Meridian Funds, managed by ArrowMark Partners, released its first-quarter 2026 investor letter for “Meridian Hedged Equity ...